NR4A1 and breast carcinoma: Before considering treatment options, the heterogeneous group of breast cancer patients was divided into subgroups [17] depending on their hormone receptor status, Her2 receptor status, histological grade [18,19,20,21], stage [20,21,22], and proliferation index in Ki67 staining [18,21,23].